Stay updated on Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Sign up to get notified when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.

Latest updates to the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page
- Check2 days agoChange DetectedThe page now indicates that no participants are being sought, signaling that enrollment is closed. In addition, new help sections (How to Read a Study Record, Common Questions, How to Join a Study) were added, the revision note was updated to v3.6.0, and the Intervention/Treatment heading was reformatted (Intervention / Treatment removed in favor of Intervention/Treatment).SummaryDifference0.5%

- Check9 days agoChange DetectedThe page's revision metadata was updated to v3.5.5, and the previous revision tag v3.5.4 was removed. Related topics entries such as 'Multiple myeloma' and 'MedlinePlus Genetics' were removed from the topics list.SummaryDifference0.2%

- Check16 days agoChange DetectedThe related topics section now lists 'Multiple myeloma' and 'MedlinePlus Genetics', connecting the study to broader disease and genetics information.SummaryDifference0.1%

- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe page revision tag was updated from v3.5.3 to v3.5.4, indicating a minor update to the record. The visible content and study details appear unchanged.SummaryDifference0.0%

- Check44 days agoChange DetectedThe MedlinePlus related topics block with links to 'Multiple Myeloma' and 'MedlinePlus Genetics' has been removed from the page, reducing quick-access background links for readers.SummaryDifference0.1%

- Check51 days agoChange DetectedAn updated citation entry is reflected for a referenced paper related to multiple myeloma, with the previously shown erratum/correction text removed. The page also shows an updated site/application revision number.SummaryDifference0.1%

Stay in the know with updates to Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembro + Lenalid Post-ASCT in High-Risk MM Clinical Trial page.